Most impactful areas to clinical real-world evidence as of 2018
Percentage of executives that said select areas would be most impactful to current and future real-world evidence (RWE) as of 2018*
This statistic depicts the percentage of executives that selected current and projected areas of most impact to real-world evidence (RWE) in clinical trials, as of 2018. According to the source, 60 percent of executives said that a better understanding of subpopulations and heterogeneity of treatment effects would be most impactful to current real-world evidence.
Percentage of executives that said select areas would be most impactful to current and future real-world evidence (RWE) as of 2018*
Loading statistic...
| Current | Future | |
|---|---|---|
| Better understanding subpopulations and heterogeneity of treatment effects | 60% | 40% |
| Understanding burdern of disease | 60% | 5% |
| Monitoring patient safety (i.e., pharmacovigilance) | 50% | 30% |
| Comparative effectiveness research | 35% | 20% |
| Supporting regulatory submission and or label expansion | 20% | 45% |
| Accelerating the execution of clinical trials using RWD as a control arm for clinical trials | 15% | 35% |
| Optimizing the design of clinical trials | 10% | 50% |
| Identifying new drug targets/areas of unmet needs | 10% | 20% |
| Design of value-based contracting schemes | 5% | 40% |
| Biomarker hypothesis generation/validation | 10% | 10% |
| Supporting patient engagement programs | 0% | 5% |
| Measuring sales performance, targeting, and marketing metrics | 0% | 0% |
| Informing business development and portfolio strategy (therapeutic area assessment) | 0% | 0% |
| Informing pricing strategies | 0% | 0% |
Source
More information
Statistics on "Clinical trials"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Presumed benefits of participation in clinical trials among adults worldwide in 2017
- Type 2 diabetes clinical trial success rates U.S. 2006-2015, by phase and indication
- Number of clinical trials for new drugs in South Korea 2012-2014
- U.S. addiction medication clinical trials in 2018, by phase and indication
- Novel pain drug clinical trials success rates U.S. 2006-2015, by phase
- Clinical trial starts for new obesity drugs U.S. 2008-2017
- U.S. abuse deterrent pain medication clinical trial starts 2006-2016, by phase
- U.S. innovative pain medication clinical trial starts 2006-2016, by phase
- Type 2 diabetes clinical pipeline in the U.S. in 2018, by type and phase
- Proportion of medicines that must be tested according to adults worldwide in 2017
- Clinical trial participants woman share worldwide 2015-16, by country
- Obesity clinical trial success rates for novel drugs U.S. 2006-2015 by phase
- U.S. pain medication clinical pipeline 2017, by type and phase
- U.S. pain medication clinical pipeline in 2017, by phase and indication
- Clinical trials starts for new type 2 diabetes drugs U.S. 2008-2017
- Clinical trial referral sources globally as of 2017
- Adults globally that understood what a clinical trial is as of 2017, by participation
- Obesity drugs clinical pipeline U.S. 2018, by type and phase
- Clinical trial sites by country development status from 2006 to 2012
- Number of active clinical trials and studies in Australia by therapeutic class 2014
Statistics on "Clinical trials"
Related topics
About Statista
